TimelyCare's AI Seal of Approval: A New Trust Benchmark in Campus Health

Fort Worth, TX – July 29, 2026 – In a move that sends a clear signal across the health-tech landscape, TimelyCare, a leading virtual care provider for the higher education market, announced it has earned full URAC accreditation for its use and development of artificial intelligence. The designation validates that the company’s AI systems meet a rigorous new set of standards for governance, ethics, and safety, establishing a critical benchmark in a field grappling with the rapid, often unregulated, advance of technology.

This accreditation is not merely a plaque on the wall; it is a foundational growth signal. For TimelyCare, which serves over 500 campuses, it provides a powerful differentiator in a crowded market. For its university partners, it offers independently verified assurance that the AI-powered tools being deployed for student well-being are built on a framework of accountability. And for the broader healthcare industry, it offers a potential blueprint for building trust while still pursuing innovation.

Setting a New Precedent for AI Governance

The credential at the center of this development is URAC’s “Artificial Intelligence in Healthcare 1.0 Developer + User Program” accreditation. Launched in September 2025 as the nation's first of its kind, the program was designed to introduce “meaningful guardrails” into the AI ecosystem, according to URAC President and CEO Shawn Griffin, MD. Its goal is to create a verifiable standard for quality and accountability in a domain where hype often outpaces responsible implementation.

Achieving the dual “Developer + User” status is significant. It signifies that TimelyCare meets URAC’s stringent criteria not only for how it deploys AI tools within its virtual care platform (the User), but also for how it builds those tools in the first place (the Developer). This comprehensive validation is designed to address the entire AI lifecycle.

The URAC review process is exhaustive, examining an organization's documented policies and practices in areas that have become flashpoints in the conversation around AI ethics. These include risk management, data protection, bias mitigation, and transparent governance. The standards require organizations to demonstrate that they have established clear clinical and technical leadership, robust workforce training, and a commitment to continuous quality improvement and performance monitoring.

“The URAC Artificial Intelligence in Healthcare Accreditation seal shows an organization’s commitment to high quality in health care,” Dr. Griffin noted, highlighting the focus on consumer protection and empowerment. For TimelyCare’s partner schools, this translates into confidence that the platform is prioritizing student privacy, equity, and safety.

Human-Centered AI in Student Well-being

Nowhere are the stakes for responsible AI higher than in healthcare, particularly when serving a student population often dealing with the acute stresses of academic life and mental health challenges. TimelyCare has been deliberate in its messaging, framing its approach as “human-centered AI” designed to augment, not automate, care.

“AI has tremendous potential to make health care easier to navigate and more responsive, but only when it is implemented with safety, discipline, transparency and human accountability,” said Luke Hejl, CEO and Co-Founder of TimelyCare. He emphasized that the accreditation provides “independent assurance that TimelyCare has built the governance, safeguards, and continuous oversight needed to use AI safely and responsibly.”

This philosophy is crucial for gaining buy-in from both clinicians and patients. Dr. Bob Booth, the company’s Chief Care Officer, reinforced this point: “At TimelyCare, technology is designed to strengthen, not replace, the expertise, empathy, and judgment of qualified professionals.” According to Booth, AI operates within defined workflows that ensure human oversight and appropriate escalation, a critical safeguard in clinical settings.

This approach directly confronts common fears about AI in healthcare—namely, the depersonalization of care and the risk of algorithmic errors in high-stakes decisions. By codifying human oversight into its accredited processes, the company aims to position its technology as a tool that empowers providers to deliver better, more efficient care, rather than as a replacement for their clinical judgment.

A Strategic Differentiator in a Competitive Market

Beyond the ethical imperative, the URAC accreditation is a shrewd strategic move. In the burgeoning virtual health market, providers are competing fiercely for contracts with universities, employers, and health systems. While features and price points are key factors, trust is emerging as a critical—and marketable—differentiator.

By becoming an early adopter of a rigorous, third-party AI validation, TimelyCare is making a bid for market leadership based on quality and safety. This signal is particularly potent in the higher education sector, where administrators and parents are intensely focused on student welfare and risk mitigation. The accreditation, which is effective through August 1, 2029, gives university decision-makers a tangible, verifiable reason to choose TimelyCare over a competitor that may lack such validation.

This move builds upon the company’s previous URAC Telehealth Accreditation from 2022, constructing a narrative of consistent commitment to the highest clinical and operational standards. In an industry where technological advancements can sometimes feel like a “wild west,” this strategy of embracing and helping to define the standards of practice can build a deep competitive moat.

Navigating the Regulatory and Ethical Frontier

TimelyCare’s achievement arrives at a pivotal moment. Policymakers and regulatory bodies are actively debating how to oversee AI in healthcare. The technology’s rapid evolution has created a regulatory gap, which industry-led initiatives like URAC’s accreditation are stepping in to fill. The significance of such programs has not gone unnoticed at the federal level; the House Appropriations Committee has already encouraged the U.S. Department of Health and Human Services to leverage accreditation to promote responsible AI.

This positions TimelyCare not just as compliant, but as a proactive participant in shaping the future of digital health governance. The accreditation provides a framework for addressing the most challenging ethical questions surrounding AI: How do you mitigate bias in algorithms to ensure equitable care? How do you protect sensitive student data while leveraging it to improve services? And who is accountable when an AI system makes a mistake?

While no accreditation can provide a perfect answer to all these questions, it forces an organization to create and document its processes for confronting them. It requires a commitment to continuous monitoring, identifying emerging risks, and clearly defining responsibility for each system. By submitting to this process, TimelyCare is signaling to the market that it is prepared for a future of increased scrutiny and is building its growth strategy on a foundation of demonstrable trust.